ALS LIMITED (ALQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALQ

ALQ - ALS LIMITED

FNArena Sector : Industrial Sector Contractors & Engineers
Year End: March
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.92
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

ALS Ltd provides laboratory and testing services across the mining, industrial and life sciences sector. It operates in over 65 countries. Formerly Campbell Brothers Ltd it first listed in 1952 and changed name to ALS in 2012.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$17.82

08 May
2025

0.460

OPEN

$17.29

2.65%

HIGH

$17.96

841,494

LOW

$17.29

TARGET
$17.75 -0.4% downside
Franking for last dividend paid out: 30%
OTHER COMPANIES IN THE SAME SECTOR
3DA . AVD . BSA . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGL . EGN . EVS . FLC . IPG . LBL . MAD . PPK . RWL . SDV . SHA . SND . SSM . SYL . VEE . VNT .
FNARENA'S MARKET CONSENSUS FORECASTS
ALQ: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 2.7 63.4 xxx
DPS (cps) xxx 39.2 38.2 xxx
EPS Growth xxx - 95.4% 100.0% xxx
DPS Growth xxx - 1.3% - 2.6% xxx
PE Ratio xxx N/A 28.4 xxx
Dividend Yield xxx N/A 2.1% xxx
Div Pay Ratio(%) xxx 1468.2% 60.2% xxx

Dividend yield today if purchased 3 years ago: 3.13%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.18

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 27/11 - ex-div 18.90c (franking 30%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx2.7
DPS All xxxxxxxxxxxxxxx39.2
Sales/Revenue xxxxxxxxxxxxxxx2,461.6 M
Book Value Per Share xxxxxxxxxxxxxxx244.4
Net Operating Cash Flow xxxxxxxxxxxxxxx359.2 M
Net Profit Margin xxxxxxxxxxxxxxx0.52 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx1.01 %
Return on Invested Capital xxxxxxxxxxxxxxx0.48 %
Return on Assets xxxxxxxxxxxxxxx0.36 %
Return on Equity xxxxxxxxxxxxxxx1.01 %
Return on Total Capital xxxxxxxxxxxxxxx15.86 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx17.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx318 M
Long Term Debt xxxxxxxxxxxxxxx1,554 M
Total Debt xxxxxxxxxxxxxxx1,872 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx300 M
Price To Book Value xxxxxxxxxxxxxxx5.37

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx151.7 M
Capex % of Sales xxxxxxxxxxxxxxx6.16 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,624 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx371 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx46 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

29/04/2025

2

Accumulate

$17.25

-3.20%

ALS Ltd announced FY25 net profit after tax guidance at $310m–$313m, which was marginally in excess of consensus according to Ord Minnett.

The broker notes mineral sample volumes rose 2.5% due to growth of 5.5% in 2H25 off a strong fourth quarter, while the environmental division is expected to achieve 10% organic growth in revenue. Food and pharmaceutical are under new leadership.

The company expects FY26 growth to return to mid-teens net profit after tax due to improving prospects for life sciences and commodities, positive forex changes, and lower net interest expenses.

Accumulate rating unchanged. Target price lifts to $17.25 from $16.05.

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

01/05/2025

3

Neutral

$14.50

-18.63%

Jarden notes ALS reaffirmed FY25 net profit guidance of $310–313m, broadly in line with consensus, though the broker questions the timing of the trading update given limited material deviation.

Geochemistry sampling volumes improved, but operating leverage appears constrained, raising concerns about potential price deflation in the Commodities segment. Life Sciences performance remains steady, though greater transparency is needed to evaluate recent acquisitions.

Jarden raises FY25 EPS slightly by 0.4%, with modest upgrades also made to FY26–27.

Despite earnings resilience, Jarden sees limited upside due to muted margin expansion and elevated balance sheet leverage, which may restrict acquisition options in FY26.

Target price lifted to $14.50 from $14.40. Neutral rating retained.

FORECAST
Jarden forecasts a full year FY25 dividend of 37.40 cents and EPS of 63.80 cents.
Jarden forecasts a full year FY26 dividend of 42.50 cents and EPS of 72.10 cents.
Access Extra Coverage Research History >

ALQ STOCK CHART

FNArena News on ALQ

1
When The Cyclical Leg Up For Imdex?

May 08 2025 - Commodities
2
Australian Broker Call *Extra* Edition – May 05, 2025

May 05 2025 - Daily Market Reports
3
Australian Broker Call *Extra* Edition – May 01, 2025

May 01 2025 - Daily Market Reports
4
Rudi’s View: Best Buys In Copper, Small Caps, Tech, Healthcare, And More

Mar 20 2025 - Rudi's View
5
Rudi’s View: Post February Conviction Calls

Mar 13 2025 - Rudi's View

Latest Industrial Sector Contractors & Engineers News

1
Southern Cross Electrical Adding Fire As Fuel

Apr 04 2025 - Small Caps
2
Rising Margins Boost ALS’ Favourable Outlook

Nov 22 2024 - Australia
3
A Golden Era For Engineering Services?

Oct 30 2024 - Feature Stories
4
How the Tides Turn: Water Scarcity And Services In Australia

Oct 14 2024 - ESG Focus
5
Transitory Headwinds For ALS

Sep 30 2024 - Australia
6
Cleanaway’s Efforts Not Wasted

Sep 23 2024 - Australia
7
IPD Group’s Future Remains Electrifying

Sep 06 2024 - Small Caps
8
It’s Electric Under The Southern Cross

Jul 24 2024 - Small Caps
9
Ventia Services: Unique Mix Of Growth & Defence

Jul 09 2024 - Small Caps
10
In The Bin; ASX-Listed Waste Companies

Nov 02 2023 - Australia